We're just two weeks away from the U.S.'s most significant AIDS
medical conference of the year, the 11th
Conference on Retroviruses and Opportunistic Infection (CROI
2004). As it has every year, CROI 2004 promises to present some
of the most cutting-edge research in HIV, and The Body has 13 HIV
specialists who will be there to cover it!
Visit our conference
home page at any time to learn more about CROI 2004 and the
talented HIV doctors who will provide our comprehensive coverage.
Have any questions about our conference coverage, or just want to
say hello? Send us an e-mail
and let us know what's on your mind!
Goldman, Editorial Director, The Body
HIV Treatment in 2003: One Wild Ride
2003 was one heck of an exciting year for HIV treatment: four
new meds were approved (including the first fusion inhibitor, a
whole new family of drugs) and researchers made great strides in
determining which regimens work best
for people taking meds for the first time. Dr. Stephen L. Becker
has more on the highs and lows of HIV treatment in 2003.
Did T-1249 Get a Red Light?
Many people were disappointed by the suspension of production
for the fusion inhibitor T-1249. Bob Huff takes a look at some of
the reasons behind the decision.
in Joining a First-Line Treatment Study?
Never been on HIV treatment? A trial in the New York City area
is now recruiting patients who have not yet taken antiretrovirals
and have a viral load of 2,000 or higher. The trial will compare
three first-line regimens. Each participant will know what combination
they will be taking.
Updates HIV Treatment Guidelines for Children (PDF)
The newly revised "Guidelines for the Use of Antiretroviral
Agents in Pediatric HIV Infection," which was released on Jan.
20, includes new information regarding the use of the newly approved
protease inhibitors 908 (fosamprenavir, Lexiva) and atazanavir (Reyataz).
The guidelines are also available
in HTML format.
Question FDA About Drug-Approval Process
How does the U.S. Food and Drug Administration (FDA) approve
new HIV meds
and how do they make sure those meds are truly safe? A group of
AIDS activists recently met with FDA officials to talk about exactly
Is Key to Drug Abuse Recovery
Joining a support group has been an important reason that Arams,
an HIV-positive recovering crystal meth user, has stayed clean. "The
biggest thing this group has done for me is to give me a place to
go," he says, "a place to share my experiences and struggles
with others who are just like me."
Insomnia: Chase Your Demons Away
Having trouble getting to sleep at night
and not because of medication side effects? Get relief
from an expert: psychologist Dr. J. Buzz von Ornsteiner serves up
advice on how to handle the stress that keeps you awake past your
to Nutrition and Exercise for People With HIV
An updated and expanded edition of Built to Survive!, a
resource book for HIV-positive men and women on nutrition, exercise
and the use of steroids, has hit the bookshelves. The book, reviewed
here by AIDS Survival Project, is authored by Nelson Vergel, who answers
questions on nutrition and exercise at The Body's "Ask the
POLICY & FUNDING (U.S.)
New Year Brings a Fresh Look at Activism's Priorities
What are some of the new issues driving AIDS activism today?
ADAP cuts and drug price hikes are just two important topics on
the 2004 agenda. GMHC's Bob Huff reviews the top stories.
AIDS Funding in the U.S. Is in Good Shape? Think Again.
Colorado AIDS treatment educator Shelley Cohen McKittrick has
a thing or two to say about the AIDS funding situation in the U.S.:
"Anyone who thinks things are going to improve in this political
climate is living in a Disney movie. As long as people who care
more about corporate bottom lines are in control of our government,
human beings will suffer."
Candidates Put Their HIV/AIDS Priorities in Writing
Six of the candidates for U.S. President have responded to an
in-depth survey on HIV/AIDS issues from AIDSVote.org. Interested
in knowing how they answered
and who didn't bother to respond? This article provides a summary.
RISK, PREVENTION & OUTREACH
Central in New York City
What is it that makes Harlem one of the New York City neighborhoods
hit hardest by AIDS? Body Positive takes a closer look at
the factors that can harm the mental and physical health of communities
like Harlem, and in doing so make them more prone to the spread
Services for Harlem Residents
Just because Harlem is considered an "underserved"
community when it comes to HIV and AIDS, that doesn't mean the community
is "unserved." There are a lot of agencies, old and new,
large and small, in and around Harlem providing prevention, treatment
and support services vital to the community, as this resource guide
from Body Positive proves.
Nasty Viruses: HIV and Hepatitis
They are three viruses with similar names
HIV, HBV (hepatitis B) and HCV (hepatitis C)
but very different personalities. Read this side-by-side comparison
of these dangerous little bugs.
Provided People Take All Their Meds
Although there are several medications that can successfully
treat tuberculosis (TB), the sheer existence of such medications
isn't enough to stop the disease: patients and doctors must also
make sure that every dose of those medications is taken, and is
taken on time. Bob Huff examines recent studies on the dilemma of
TB treatment adherence.
Releases Updated Guidelines on Group of Tuberculosis Drugs
The U.S. Centers for Disease Control and Prevention (CDC) has
released updated guidelines for the use of rifamycins, a family
of drugs used to treat tuberculosis, in people with HIV who are
taking protease inhibitors or NRTIs.
The online version is also available at the CDC's
Efficacy of Topical Therapy With a Slow-Release Mucoadhesive Buccal
Tablet Containing Miconazole Nitrate Versus Systemic Therapy With
Ketoconazole in HIV-Positive Patients With Oropharyngeal Candidiasis
A once-daily topical treatment for oral thrush has
been found just as effective as traditional therapy, which often
involves using prescription lozenges or mouthwashes as many as five
times a day.
From JAIDS, February 1, 2004
and Drugs Linked With Rectal Gonorrhea in Gay Men in San Francisco
HIV-positive gay men are twice as likely to have rectal gonorrhea
as HIV-negative gay men, this study found. Infection was even more
likely if the men had recently had unprotected receptive anal sex,
met an anonymous partner at a sauna or used recreational drugs,
From aidsmap.com, January 28, 2004
I Will Live Longer"
Last week, Xolile Maliti became the first person
to receive free HIV meds through South Africa's new treatment program.
But is the program's rollout taking too long?
From the Mail & Guardian (Johannesburg), January 23,
Admits Error in Study on HIV Survival
Prominent AIDS researcher Dr. David Ho has backtracked on a major
finding he and his colleagues announced last year. Ho mistakenly
thought he had discovered the cause of the so-called "CD8 antiviral
factor," which scientists believe may be what keeps long-term
HIV nonprogressors from developing AIDS.
From the San Francisco Chronicle, January 23, 2004
Health AIDS Newsletter, Winter 2004 (PDF)
Included in this quarterly update on mental health and AIDS is a
summary of clinical recommendations and published research regarding
the psychological factors that influence sexual risk behavior between
From the AETC National Resource Center, Winter 2004
at The Body to learn more about clinical trials that may be
a good match for you!